Hear more about the top reasons the birth control pill should be OTC from Power to Decide's CEO Dr. Raegan McDonald-Mosley and join the movement to #FreeThePill.
Educational MaterialsGet patient educational materials, the kind they'll actually read.
Tearsheets, postcards, and posters with just the right amount of information. Order now from the Power to Decide store.
NewsletterSign up for our newsletter
You'll stay on top of everything that's happening with Bedsider Providers and get a discount on our best materials including t-shirts, posters, tear sheets, DVDs, and more!
A practical guide for providers to provide trauma-informed physical examinations.
What providers need to know to answer patients' questions about OTC birth control pills.
Initial reports from the ongoing narrative collection Care Post Roe documenting poor-quality care, patient perspectives on telehealth medication abortion, adolescent preferences and experiences with pregnancy options counseling, and more.
A sample protocol for medication abortion with misoprostol alone, support for EC educational material, people’s experiences with travel for abortions later in pregnancy.
COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!
Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.
What providers need to know about how to screen, what to look for, and what to do next.
What you need to know about pharmacist prescribing and how it can increase access to birth control.
A systemic review of “no-test” medication abortion, using an allis clamp during IUD placement, a trial of gabapentin for pain management during second-trimester abortions, and at-home urine pregnancy testing for follow-up of immediate management of an undesired pregnancy of unknown location.
What providers need to know about the December 2022 updates to levonorgestrel emergency contraception (LNG-EC) labeling.
Providers are a critical link for abortion seekers.
Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.
New maps on AbortionFinder.org show the number of in-person providers offering abortion and the latest gestational age that abortion has been available by state from the end of April 2022 to today—a powerful overview of the new and harmful chapter for abortion access.
Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.
What providers need to know for counseling patients and managing their pain during IUD insertion.
Support for safety and efficacy of self-managed misoprostol-only medication abortion, medication abortion information on TikTok, and the impact of the shot and IUDs on vaginal flora.